Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Pende

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|December 17, 2021
ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell FunctionSilvia D'Amico, Valerio D'Alicandro, Mirco Compagnone, et al.
Cancer Immunology, Immunotherapy : CII|August 21, 2015
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemiasGabriella Pietra, Chiara Vitale, Daniela Pende, et al.
HLA|April 19, 2022
Characterization of KIR<sup>+</sup> NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA-CRaffaella Meazza, Michela Falco, Paolo Canevali, et al.
European Journal of Immunology|February 6, 2014
XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cellsRaffaella Meazza, Claudia Tuberosa, Valentina Cetica, et al.
Frontiers in Immunology|June 25, 2019
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical ExploitationDaniela Pende, Michela Falco, Massimo Vitale, et al.
The Journal of Experimental Medicine|August 13, 2003
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating moleculeCristina Bottino, Roberta Castriconi, Daniela Pende, et al.
Frontiers in Immunology|July 19, 2019
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and MoreMassimo Vitale, Claudia Cantoni, Mariella Della Chiesa, et al.
Blood|August 26, 2004
HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cellsEnnio Carbone, Paola Neri, Maria Mesuraca, et al.
Plos Pathogens|July 12, 2008
Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individualsManuela Fogli, Domenico Mavilio, Enrico Brunetta, et al.
Blood|November 24, 2005
Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interactionDaniela Pende, Roberta Castriconi, Paola Romagnani, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|December 17, 2021
ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell FunctionSilvia D'Amico, Valerio D'Alicandro, Mirco Compagnone, et al.
Cancer Immunology, Immunotherapy : CII|August 21, 2015
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemiasGabriella Pietra, Chiara Vitale, Daniela Pende, et al.
HLA|April 19, 2022
Characterization of KIR<sup>+</sup> NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA-CRaffaella Meazza, Michela Falco, Paolo Canevali, et al.
European Journal of Immunology|February 6, 2014
XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cellsRaffaella Meazza, Claudia Tuberosa, Valentina Cetica, et al.
Frontiers in Immunology|June 25, 2019
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical ExploitationDaniela Pende, Michela Falco, Massimo Vitale, et al.
The Journal of Experimental Medicine|August 13, 2003
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating moleculeCristina Bottino, Roberta Castriconi, Daniela Pende, et al.
Frontiers in Immunology|July 19, 2019
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and MoreMassimo Vitale, Claudia Cantoni, Mariella Della Chiesa, et al.
Blood|August 26, 2004
HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cellsEnnio Carbone, Paola Neri, Maria Mesuraca, et al.
Plos Pathogens|July 12, 2008
Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individualsManuela Fogli, Domenico Mavilio, Enrico Brunetta, et al.
Blood|November 24, 2005
Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interactionDaniela Pende, Roberta Castriconi, Paola Romagnani, et al.
Pageof 11